Procyon Advisors, LLC Novo Nordisk A S Transaction History
Procyon Advisors, LLC
- $1.44 Billion
- Q3 2024
A detailed history of Procyon Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Procyon Advisors, LLC holds 63,649 shares of NVO stock, worth $6.87 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
63,649
Previous 59,639
6.72%
Holding current value
$6.87 Million
Previous $8.51 Million
10.97%
% of portfolio
0.53%
Previous 0.64%
Shares
11 transactions
Others Institutions Holding NVO
# of Institutions
1,956Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$2.18 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.55 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.55 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.44 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.32 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $244B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...